Announcements Trials
Browse Landscape

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 44Observational 4

Sponsor

Cancer Type

Breast 3Gastrointestinal 1

Conditions

Breast Neoplasms 3Stomach Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1

Interventions

Blood Specimen Collection 137Surveys and Questionnaires 131Specimen Handling 57Observation 55Radiotherapy 44Interviews as Topic 35Drug Therapy 31Surgical Procedures, Operative 31Biopsy 30Data Collection 25Magnetic Resonance Spectroscopy 25Nivolumab 21Watchful Waiting 20Immune Checkpoint Inhibitors 19Magnetic Resonance Imaging 17Standard of Care 17Therapeutics 17Immunotherapy 16palbociclib 14trastuzumab deruxtecan 14Liquid Biopsy 13Restraint, Physical 13Tomography, X-Ray Computed 13Hematologic Tests 12Radiosurgery 12Focus Groups 11Genetic Testing 11darolutamide 11enzalutamide 11pembrolizumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Ado-Trastuzumab Emtansine × 1 year × Clear all
NCT06663787 2026-05-13

HER2 CR

Nagoya City University

Active not recruiting
50 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

NCT04158258 2026-04-23

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Hoffmann-La Roche

Active not recruiting
2,907 enrolled
Breast

Breast Neoplasms

NCT07389876 2026-02-05

G/GEJ

Fudan University

Recruiting
250 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05945927 2025-10-10

A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer

Hoffmann-La Roche

Completed
178 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡